Oncology Products: Manufacturing, Regulatory, and Safety Aspects of Anticancer Drugs
Oncology pharmaceuticals are classified based on their mechanism of action:Click to read the full article.
Oncology Products
Oncology Product Quality Risks? Containment, OEL, and Process Controls Solutions
Detection of quality issues regarding oncology products often occurs through a variety of symptoms or signals noted during manufacturing or analytical testing. Understanding these signals is paramount for rapid response…
Cross-contamination risk during stability pull: FDA/EMA investigation expectations
Identifying symptoms of cross-contamination during stability pulls can be crucial in preventing wider issues. Indicators can be both operational and analytical:Click to read the full article.
Cross-contamination risk during inspection prep: risk assessment for patient safety
Assessing Cross-Contamination Risks During Inspection Preparation in Pharma Manufacturing Cross-contamination risk during inspection preparation can pose significant challenges to pharmaceutical manufacturing, especially in sectors like oncology where patient safety is…
Cross-contamination risk during shared facility campaign: risk assessment for patient safety
Identifying symptoms or signals of potential cross-contamination is the first step in mitigating risks. These signals can manifest as deviations from expected outcomes, which include:Click to read the full article.
Cross-contamination risk during inspection prep: containment CAPA and effectiveness checks
Identifying signals of potential cross-contamination is crucial for timely intervention. Symptoms may manifest in several forms, often recognized during routine checks or specific inspection preparations:Click to read the full article.
Stability failure after equipment cleaning: containment CAPA and effectiveness checks
Identifying symptoms or signals is the first step in addressing stability failures. In a manufacturing environment, various indicators may suggest that a stability issue has arisen following equipment cleaning:Click to…
Cross-contamination risk during stability pull: containment CAPA and effectiveness checks
Identifying signals indicating potential cross-contamination is crucial for timely intervention. Symptoms can manifest in various ways, including unexpected stability test results, complaints regarding product quality from either internal teams or…
Cross-contamination risk after equipment cleaning: containment CAPA and effectiveness checks
Identifying symptoms or signals of potential cross-contamination is the first step in the investigation process. Symptoms may vary across different production processes. Common indicators include:Click to read the full article.
Assay drift during stability pull: risk assessment for patient safety
The first step in addressing assay drift during stability pulls is to identify the specific symptoms or signals. These indicators can manifest in various ways:Click to read the full article.
Potency OOS after equipment cleaning: risk assessment for patient safety
Symptoms or signals on the manufacturing floor and laboratory provide critical indicators of possible potency OOS events. Below are key signs to monitor:Click to read the full article.
Stability failure during stability pull: containment CAPA and effectiveness checks
The initial identification of a stability failure during stability pull typically arises from various symptoms observed on the production floor or within laboratory settings. Key signals may include:Click to read…